Selectquote, INC 8-K filings

SelectQuote, Inc. announced its third quarter fiscal year 2026 financial results, showcasing revenue growth and improved profitability.

SelectQuote, Inc. received a notice from the NYSE for non-compliance due to its common stock trading below $1.00 for 30 consecutive days, initiating a six-month cure period.

SelectQuote, Inc. reported a 12% increase in consolidated revenue for the second quarter of fiscal year 2026, reaching $537.1 million, but revised its full-year guidance downwards due to partner-driven headwinds.

SelectQuote, Inc. announced a new $415 million credit facility, comprising a $325 million term loan and a $90 million revolving credit facility, significantly extending its debt maturity to January 2031 and enhancing liquidity.

SelectQuote, Inc. announced the successful outcome of its 2025 Annual Meeting of Stockholders, with all management-backed proposals passing.

SelectQuote, Inc. reported consolidated revenue of $328.8 million for the first quarter of fiscal year 2026, driven by strong performance in its Healthcare Services segment, despite a consolidated Adjusted EBITDA loss worse than guidance.

SelectQuote, Inc. reported a return to consolidated net income of $12.9 million for the fourth quarter of fiscal year 2025, driven by significant growth in its Healthcare Services segment.

SelectQuote, Inc. announced robust fiscal year 2025 results, exceeding internal expectations for the third consecutive year, driven by significant growth in its Healthcare Services segment and a strengthened capital structure.

SelectQuote, Inc. has amended its Credit Agreement, extending the revolving facility termination date to September 30, 2027, and adjusting the term loan maturity date.

SelectQuote, Inc. announced the passing of William T. Grant II, Vice Chairman of the Board of Directors and former President, a pivotal figure in the company's strategic evolution.

SelectQuote, Inc. announced its third quarter fiscal year 2025 results, highlighting revenue growth and strong performance in its Senior segment.

SelectQuote completed a $350 million investment deal by issuing preferred stock and warrants to NL Monarch Holdings LLC (Morgan Stanley) and NL Monarch Holdings II LLC (Bain).

SelectQuote announces a $350 million strategic investment from Bain Capital and Morgan Stanley Private Credit to enhance growth and improve its capital structure.

SelectQuote, Inc. held its 2024 Annual Meeting of Stockholders on November 12, 2024, and announced the results of voting on key proposals.

SelectQuote's first quarter of fiscal year 2025 shows significant revenue growth and improved profitability, leading to an increased full-year outlook.

SelectQuote, Inc. has entered into a $100 million asset-backed securities facility, backed by a portion of its commissions receivable, and amended its senior secured credit facility.

SelectQuote completed a $100 million securitization transaction, extending debt maturity and lowering its cost of capital.

SelectQuote's fiscal year 2024 saw significant revenue growth and improved profitability, with the company also announcing a plan to securitize approximately $100 million in commission receivables.

SelectQuote exceeded expectations for the ninth consecutive quarter, reporting increased revenue and adjusted EBITDA, and raising its full-year guidance.

SelectQuote, Inc. announced strong second quarter fiscal year 2024 results, exceeding expectations and raising full-year guidance across all key metrics.